创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology: iHuPBMC-B Mouse Model

  • Categories:Company news
  • Author:InnoModels Biotechnology
  • Origin:InnoModels Biotechnology
  • Time of issue:2024-01-22 15:24
  • Views:

(Summary description)InnoModels Bio's iHuPBMC-B mouse model is a leading biomedical research technology focused on providing high quality B lymphocyte products to support researchers with superior tools and resources in the fields of Immunology, Infectious Diseases, Cancer Research and more

InnoModels Biotechnology: iHuPBMC-B Mouse Model

(Summary description)InnoModels Bio's iHuPBMC-B mouse model is a leading biomedical research technology focused on providing high quality B lymphocyte products to support researchers with superior tools and resources in the fields of Immunology, Infectious Diseases, Cancer Research and more

  • Categories:Company news
  • Author:InnoModels Biotechnology
  • Origin:InnoModels Biotechnology
  • Time of issue:2024-01-22 15:24
  • Views:
Information

InnoModels Bio's iHuPBMC-B mouse model is a leading biomedical research technology focused on providing high quality B lymphocyte products to support researchers with superior tools and resources in the fields of Immunology, Infectious Diseases, Cancer Research and more.
1. High-efficiency production technology for B lymphocytes: iHuPBMC-B utilizes advanced cell culture and expansion technology to efficiently obtain B lymphocytes from human Peripheral Blood Mononuclear Cells (PBMCs). This ensures that the resulting B lymphocytes have a high degree of activity and functional integrity.
2. Multiple applications: iHuPBMC-B products have a wide range of applications in various research fields such as immunology research, infectious diseases, cancer immunotherapy, and so on. Researchers can utilize these highly efficient B-lymphocytes for in vitro experiments, drug screening, disease modeling studies, etc.

 


3. Customized service:InnoModels Biotechnology provides customized service, supplying different types and quantities of B lymphocytes according to customers' needs to meet the requirements of various research projects. This personalized service enables researchers to better meet the specific needs of their experiments.
4. Strict quality control: The company carries out strict quality control of iHuPBMC-B products to ensure that each batch of B lymphocytes meets high quality standards. This helps to ensure the reliability and reproducibility of the experimental results.
5. Reliable Supply Chain: The production of iHuPBMC-B products adopts efficient supply chain management to ensure that customers can obtain the required B lymphocytes in a timely manner, and the progress of research will not be affected by supply problems.
By providing high-quality and highly active B lymphocyte products, iHuPBMC-B from InnoModels Biotechnology provides scientists in the field of immunology research with a key research tool, providing strong support for in-depth understanding of the complex mechanisms of the immune system, the onset and progression of disease, and the discovery of new therapeutic approaches.

Keyword:

In the vast starry sky of biomedical research, InnoModels Biotechnology (Beijing) Co., Ltd. is like a bright star, illuminating the journey of oncology and tumor immunology drug development with its unique PDX in vivo efficacy model. Today, let's go into InnoModels Biotechnology to learn more about its industry-leading PDX in vivo efficacy model and explore its unlimited potential in drug discovery and development.
In the vast field of cancer research and drug development, InnoModels Biotechnology (Beijing) Co., Ltd. provides powerful support to scientists and doctors with its leading CDX (Cell line-derived xenograft tumor) model platform. The platform not only has diverse tumor cell lines, but also is equipped with a team of experienced experts and advanced experimental technologies, which are dedicated to promoting innovation in biomedical research and clinical treatment.
In the field of life sciences, in vitro killing experimental platform is gradually becoming an important tool for drug development and cell research. Among them, the in vitro killing experimental platform of InnoModels Biotechnology has attracted the attention of many researchers with its unique technical advantages and wide application prospects. In this paper, we will introduce in detail the features and advantages of InnoModels' in vitro killing platform and its applications in scientific research.
In the vast starry sky of biomedical research, InnoModels Biotechnology (Beijing) Co., Ltd. is leading the forefront of tumor and tumor immunotherapy research with its unique in vivo tumor experimental platform, which is like a bright star. The platform not only integrates the most advanced technologies and experimental methods, but also devotes itself to providing a new generation of experimental animal models close to the clinic
In the vast field of life science and drug discovery, in vitro experimental platforms play a crucial role. As a leader in this field, InnoModels Biotechnology (Beijing) Co., Ltd. provides scientists with a highly controlled and precise experimental environment with its in vitro killing platform, which greatly facilitates the screening of new drugs, the study of drug mechanisms, and the development of immunotherapies.
In the broad field of tumor research and new drug development for tumor immunotherapy, InnoModels Biotechnology (Beijing) Co., Ltd. has successfully launched a high mesenchymal tumor transplantation model by virtue of its profound accumulation and technological innovation in the field of model construction, which provides strong support for tumor research and drug development. In this article, we will introduce in detail how InnoModels Biotechnology has made a breakthrough in this field, and explain the importance of high mesenchymal tumor models and their application prospects.
Previous page
1
2
42

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司